Multimeric RGD-Based Strategies for Selective Drug Delivery to Tumor Tissues - Département de Chimie Moléculaire Accéder directement au contenu
Article Dans Une Revue Pharmaceutics Année : 2023

Multimeric RGD-Based Strategies for Selective Drug Delivery to Tumor Tissues

Jordan Cossu
  • Fonction : Auteur
Fabien Thoreau

Résumé

RGD peptides have received a lot of attention over the two last decades, in particular to improve tumor therapy through the targeting of the αVβ3 integrin receptor. This review focuses on the molecular design of multimeric RGD compounds, as well as the design of suitable linkers for drug delivery. Many examples of RGD–drug conjugates have been developed, and we show the importance of RGD constructs to enhance binding affinity to tumor cells, as well as their drug uptake. Further, we also highlight the use of RGD peptides as theranostic systems, promising tools offering dual modality, such as tumor diagnosis and therapy. In conclusion, we address the challenging issues, as well as ongoing and future development, in comparison with large molecules, such as monoclonal antibodies.
Fichier principal
Vignette du fichier
pharmaceutics 2023.pdf (2.25 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03986719 , version 1 (13-02-2023)

Identifiants

Citer

Jordan Cossu, Fabien Thoreau, Didier Boturyn. Multimeric RGD-Based Strategies for Selective Drug Delivery to Tumor Tissues. Pharmaceutics, 2023, 15 (2), pp.525. ⟨10.3390/pharmaceutics15020525⟩. ⟨hal-03986719⟩
8 Consultations
40 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More